Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions

Clinical and Experimental Metastasis

Volumn 29, Issue 2, 2012, Pages 83-89

  Park, Do Sim ^a   Hwang, Ki Eun ^a   Shim, Hyeok ^a   Kim, Byoung Ryun ^a   Choi, Keum Ha ^a   Park, Seong Hoon ^a   Park, Seok Don ^a   Jeong, Eun Taik ^a   Kim, Hak Ryul ^a  

^a Wonkwang University   (South Korea)

Author keywords

Chemotherapy; Lung cancer; Pleural effusion; Prognosis; Survival; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUBERCULOSIS; UNIVARIATE ANALYSIS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84857168954     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9431-7     Document Type: Article

References (28)

1. A Memon ZA Zawadzki 1981 Malignant effusions: diagnostic evaluation and therapeutic strategy Curr Probl Cancer 5 1 30 6263549 10.1016/S0147-0272(81) 80012-8 1:STN:280:DyaL3M3htFantw%3D%3D
2. CB Anderson GW Philpott TB Ferguson 1974 The treatment of malignant pleural effusions Cancer 33 916 922 4362107 10.1002/1097-0142(197404)33: 4<916::AID-CNCR2820330405>3.0.CO;2-U 1:STN:280:DyaE2c7jtF2msQ%3D%3D
3. M Fiegl A Massoner M Steurer, et al. 2003 Improving tumor cell detection in pleural effusions by interphase cytogenetics Cytometry B Clin Cytom 55 60 62 12949962 10.1002/cyto.b.10046 (Pubitemid 38295411)
4. Ferrer J, Villarino MA, Encabo G et al. (1999) Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 86:1488-1495 (Pubitemid 29489782)
5. M Miedouge P Rouzaud G Salama, et al. 1999 Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions Br J Cancer 81 1059 1065 10576665 10.1038/sj.bjc.6690807 1:STN:280:DC%2BD3c%2Fkt1Srtg%3D%3D (Pubitemid 29516152)
6. P Gu G Huang Y Chen, et al. 2007 Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis J Clin Lab Anal 21 398 405 18022924 10.1002/jcla.20208 1:CAS:528:DC%2BD1cXpvVKntQ%3D%3D (Pubitemid 350250409)
7. MJ Gaspar J De Miguel JD Garcia Diaz, et al. 2008 Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions Anticancer Res 28 2947 2952 19031938 1:CAS:528:DC%2BD1cXhsVaitrjK
8. QL Liang HZ Shi XJ Qin, et al. 2008 Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis Thorax 63 35 41 17573438 10.1136/thx.2007.077958
9. EC LaCasse S Baird RG Korneluk, et al. 1998 The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 3247 3259 9916987 10.1038/sj.onc.1202569 (Pubitemid 29043977)
10. G Ambrosini C Adida DC Altieri 1997 A novel anti-apoptosis gene, surviving, expressed in cancer and lymphoma Nat Med 3 917 921 9256286 10.1038/nm0897-917 1:CAS:528:DyaK2sXltVylt7w%3D (Pubitemid 27353455)
11. H Kawasaki DC Altieri CD Lu, et al. 1998 Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer Cancer Res 58 5071 5074 9823313 1:CAS:528:DyaK1cXnsFSmt78%3D (Pubitemid 28521163)
12. AB Als L Dyrskjot H von der Maase, et al. 2007 Emmprin and surviving predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer Clin Cancer Res 13 4407 4414 17671123 10.1158/1078-0432.CCR-07-0109 1:CAS:528:DC%2BD2sXotlGqtrY%3D (Pubitemid 47219707)
13. Y Nakagawa S Abe M Kurata, et al. 2006 IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes Am J Hematol 81 824 831 16929535 10.1002/ajh.20656 1:CAS:528:DC%2BD28Xht1Oisb7N (Pubitemid 44682183)
14. R Watanuki-Miyauchi Y Kojima H Tsurumi, et al. 2005 Expression of surviving and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes Pathol Int 55 324 330 15943789 10.1111/j.1440-1827.2005.01832.x 1:CAS:528: DC%2BD2MXmsFOhtbo%3D (Pubitemid 40910665)
15. MJ Duffy N O'Donovan DJ Brennan, et al. 2007 Survivin: a promising tumor biomarker Cancer Lett 2491 49 60 10.1016/j.canlet.2006.12.020 (Pubitemid 46442669)
16. DC Altieri 2008 Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 81 61 70 10.1038/nrc2293
17. YK Wu KT Chen YB Kuo, et al. 2009 Quantitative detection of surviving in malignant pleural effusion for the diagnosis and prognosis of lung cancer Cancer Lett 273 331 335 18824294 10.1016/j.canlet.2008.08.023 1:CAS:528: DC%2BD1cXhsV2gtbjI
18. RW Light 1997 Diagnostic principles in pleural disease Eur Respir J 10 476 481 9042652 10.1183/09031936.97.10020476 1:STN:280:DyaK2s7psFantw%3D%3D (Pubitemid 27063871)
19. PE Postmus E Brambilla K Chansky, et al. 2007 The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forth-coming (seventh) edition of the TNM classification of lung cancer J Thorac Oncol 2 686 693 17762334 10.1097/JTO.0b013e31811f4703 (Pubitemid 47357520)
20. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280: DyaK2szjtVOguw%3D%3D (Pubitemid 27260107)
21. CD Lu DC Altieri N Tanigawa 1998 Expression of a novel apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res 58 1808 1812 9581817 1:CAS:528:DyaK1cXislensbs%3D (Pubitemid 28217451)
22. N Takai T Miyazaki M Nishida 2002 Survivin expression correlates with clinical stages, histologic grade, invasive behavior and survival rates in endometrial carcinoma Cancer Lett 184 105 116 12104054 10.1016/S0304-3835(02) 00190-8 1:CAS:528:DC%2BD38XkvFyktb4%3D (Pubitemid 34718112)
23. J Kato Y Kuwabara M Mitani, et al. 2001 Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 92 95 11241318 10.1002/1097-0215(20010320)95:2<92::AID- IJC1016>3.0.CO;2-9 1:CAS:528:DC%2BD3MXitV2ks7w%3D (Pubitemid 32187079)
24. N Zaffaroni M Pennati G Colella, et al. 2002 Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer Cell Mol Life Sci 59 1406 1412 12363043 10.1007/s00018-002-8518-3 1:CAS:528:DC%2BD38XntFGls7g%3D
25. B Vischioni P van der Valk SW Span, et al. 2004 Nuclear location of survivin is a positive prognostic factor for survival in advanced NSCLC Ann Oncol 15 1654 1660 15520067 10.1093/annonc/mdh436 1:STN:280: DC%2BD2crkslSksQ%3D%3D (Pubitemid 39562606)
26. B Karczmarek-Borowska A Filip J Wojcierowski, et al. 2005 Survivn antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study Folia Histochem Cytobiol 43 237 242 16382892 1:CAS:528:DC%2BD28XktVeqtw%3D%3D (Pubitemid 41582146)
27. W Naumnik W Nilklinska M Ossolinska, et al. 2009 Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy Folia Histochem Cytobiol 47 703 709 20430742 10.2478/v10042-009- 0025-z 1:CAS:528:DC%2BC3MXitlemtL0%3D
28. M Falleni C Pellegrini A Marchetti, et al. 2003 Survivin gene expression in early non-small cell lung cancer J Pathol 200 620 626 12898598 10.1002/path.1388 1:CAS:528:DC%2BD3sXntl2nurk%3D (Pubitemid 36987311)